Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STS-01 in Mild-Moderate Alopecia Areata
NCT06402630Phase 2Completed
- Sponsor
- Soterios Pharma
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STS-01 in alopecia areata, sponsored by Soterios Pharma. Started Mar 2022; status: completed.
02
Drugs
STS-01
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06402630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402630.